InsiderTrades

Form 4 for TKR TIMKEN CO

Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-07 · accession 0000098362-23-000112 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-08-08 2023-08-07 TKR Kyle Richard G Pres, CEO, Dir M - OptEx $42.60 +40.0K 423.1K +10% +$1.70M
D 2023-08-08 2023-08-07 TKR Kyle Richard G Pres, CEO, Dir F - Tax $80.49 -8,067 415.0K -2% -$649.3K
DM 2023-08-08 2023-08-07 TKR Kyle Richard G Pres, CEO, Dir S - Sale+OE $80.06 -31.9K 383.1K -8% -$2.56M
D 2023-08-08 2023-08-07 TKR Kyle Richard G Pres, CEO, Dir M - OptEx $0.00 -40.0K 40.0K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-07 M A 40,000 $42.60 423,082 D — —
2 Common Common Stock 2023-08-07 F D 8,067 $80.49 415,015 D — —
3 Common Common Stock 2023-08-07 S D 29,843 $80.02 385,172 D — — (F1) This transaction was executed in multiple trades at prices ranging from $79.61 to $80.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4 Common Common Stock 2023-08-07 S D 2,090 $80.67 383,082 D — — (F2) This transaction was executed in multiple trades at prices ranging from $80.61 to $80.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5 Derivative Employee Stock Option (right to buy) 2023-08-07 M D 40,000 $0.00 40,000 D $42.60 · 2020-02-12 to 2029-02-12 40,000 Common Stock (F3) 40,000 stock options from 2/12/2019 grant of 138,425 stock options (previously reported) that vested in 25% increments per year from the date of grant.